Skip to main content
Watch Insiders
VRCAHealthcare

Verrica Pharmaceuticals Inc (VRCA) Insider Trading

In the last 90 days, 4 Verrica Pharmaceuticals Inc (VRCA) insiders reported 4 open-market purchases totaling $210,890 and no sales. The most recent open-market purchase was reported on Aug 18, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
4
90-day purchase value
$210,890
Corporate buyers
4
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026Noah L. RosenbergCMOOpen Market Purchase6,230$4.91$30,610
Aug 18, 2026John J. KirbyInterim CFOOpen Market Purchase5,000$4.93$24,650
Aug 17, 2026David ZawitzChief Operating OfficerOpen Market Purchase6,000$4.98$29,880
Aug 17, 2026Jayson RiegerCEO and PresidentOpen Market Purchase25,000$5.03$125,750

Common questions

VRCA insider trading FAQ

Are VRCA insiders buying or selling?
Over the last 90 days, VRCA insiders were net buyers, reporting $210,890 of open-market purchases and $0.00 of sales.
When was the last VRCA insider purchase?
The most recent open-market purchase of Verrica Pharmaceuticals Inc stock by an insider was reported on Aug 18, 2026, one of 4 purchases in the last 90 days.
Where does VRCA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Verrica Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.